User profiles for Vana Sypsa
 | Vana SypsaProfessor, National and Kapodistrian University of Athens Verified email at med.uoa.gr Cited by 13191 |
Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems
…, A Argyropoulou, I Stefanou, V Sypsa… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Carbapenemase-producing Klebsiella pneumoniae strains (CP-Kps) are currently among
the most important nosocomial pathogens. An observational study was conducted during …
the most important nosocomial pathogens. An observational study was conducted during …
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
Background & Aims Risk scores for hepatocellular carcinoma (HCC) developed in Asians
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
offer poor-moderate predictability in Caucasian patients with chronic hepatitis B (CHB). This …
The effectiveness of a 9-month regimen of isoniazid alone versus 3-and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in …
…, PG Spyridis, A Gelesme, V Sypsa… - Clinical Infectious …, 2007 - academic.oup.com
Background. A 9-month course of isoniazid monotherapy is currently recommended for the
treatment of latent tuberculosis infection (LTBI) and has been shown to be effective in both …
treatment of latent tuberculosis infection (LTBI) and has been shown to be effective in both …
[HTML][HTML] aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Background & Aims Hepatocellular carcinoma (HCC) is the leading cause of death in patients
with chronic hepatitis. In this international collaboration, we sought to develop a global …
with chronic hepatitis. In this international collaboration, we sought to develop a global …
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
Whether there is a change of hepatocellular carcinoma (HCC) incidence in chronic hepatitis
B patients under long‐term therapy with potent nucleos(t)ide analogues is currently unclear. …
B patients under long‐term therapy with potent nucleos(t)ide analogues is currently unclear. …
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and
mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting …
mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting …
Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis
…, E Hatzitheodorou, Z Moschidis, V Sypsa… - Clinical Infectious …, 2009 - academic.oup.com
Background . The effect of hepatitis B virus (HBV) infection on the natural history of human
immunodeficiency virus (HIV) disease remains uncertain. Therefore, a retrospective cohort …
immunodeficiency virus (HIV) disease remains uncertain. Therefore, a retrospective cohort …
[HTML][HTML] Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Background People who inject drugs (PWID) are at increased risk for HIV and hepatitis C
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
Background & Aims The risk of hepatocellular carcinoma (HCC) in Caucasian patients with
chronic hepatitis B (CHB), treated with entecavir (ETV) or tenofovir (TDF), is unclear. We …
chronic hepatitis B (CHB), treated with entecavir (ETV) or tenofovir (TDF), is unclear. We …
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B
Background & Aims Several models have recently been developed to predict risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …